Cai Bin, Zeng Jiabin, Lin Yi, Lin Yu, Lin WenPing, Lin Wei, Li Zhiwen, Wang Ning
Department of Neurology and Institute of Neurology, First Affiliated Hospital, Fujian Medical University, 20 Chazhong Road, Fuzhou, 350005, Fujian, China.
Neurol Sci. 2015 Aug;36(8):1387-91. doi: 10.1007/s10072-015-2121-5. Epub 2015 Mar 13.
Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL) is a rare hereditary cerebral artery disease. The HtrA serine protease 1 (HTRA1) gene has been identified as the causative gene of CARASIL. Here, we report a novel mutation in the HTRA1 gene in a CARASIL pedigree and explore its pathogenesis at the protein level. Subcutaneous tissue biopsy and HTRA1 gene analysis were performed in a CARASIL patient, and HTRA1 and TGF-β1 protein expression in subcutaneous tissue and cultured fibroblasts from the proband were detected by immunohistochemistry and western blotting. A 28-year-old male proband and his brother experienced recurrent stroke, hair loss and low back pain. Abnormalities in the proband were found in the elastic plate of subcutaneous small arteries, and a novel homozygous frameshift mutation (c.161_162insAG), leading to the formation of a stop codon 159 amino acids downstream of the insertion (p.Gly56Alafs*160) was detected. Reduced HTRA1 protein and increased TGF-β1 expression were detected in subcutaneous tissue and in cultured fibroblasts. A frameshift mutation in the HTRA1 gene detected in a CARASIL pedigree resulted in reduced HTRA1 protein and increased TGF-β1 expression, which may cause severe CARASIL and peripheral small arterial disease.
伴有皮质下梗死和白质脑病的常染色体隐性遗传性脑动脉病(CARASIL)是一种罕见的遗传性脑动脉疾病。HtrA丝氨酸蛋白酶1(HTRA1)基因已被确定为CARASIL的致病基因。在此,我们报告了一个CARASIL家系中HTRA1基因的一个新突变,并在蛋白质水平上探讨其发病机制。对一名CARASIL患者进行了皮下组织活检和HTRA1基因分析,并通过免疫组织化学和蛋白质印迹法检测了先证者皮下组织和培养的成纤维细胞中HTRA1和TGF-β1蛋白的表达。一名28岁的男性先证者及其兄弟出现复发性中风、脱发和腰痛。在先证者的皮下小动脉弹性板中发现异常,并检测到一个新的纯合移码突变(c.161_162insAG),导致在插入下游159个氨基酸处形成一个终止密码子(p.Gly56Alafs*160)。在皮下组织和培养的成纤维细胞中检测到HTRA1蛋白减少和TGF-β1表达增加。在一个CARASIL家系中检测到的HTRA1基因移码突变导致HTRA1蛋白减少和TGF-β1表达增加,这可能导致严重的CARASIL和外周小动脉疾病。